DESARG9-D-ARG[HYP3,THI5,D-TIC7,OIC8]BRADYKININ (DESARG10-[HOE140]) IS A POTENT BRADYKININ-B1 RECEPTOR ANTAGONIST

被引:70
作者
WIRTH, K
BREIPOHL, G
STECHL, J
KNOLLE, J
HENKE, S
SCHOLKENS, B
机构
[1] Hoechst AG
关键词
DESARG9-D-ARG[HYP3; THI5; D-TIC7; OIC8]BRADYKININ; HOE140; BRADYKININ RECEPTOR ANTAGONISTS; BRADYKININ-B1; RECEPTORS; BRADYKININ-B2;
D O I
10.1016/0014-2999(91)90824-A
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
DesArg9-D-Arg[Hyp3,Thi5,D-Tic7,OiC8]BK is a potent and stable B1 bradykinin (BK) receptor antagonist which was one order of magnitude more potent (IC50 1.2 x 10(-8) M) in the isolated rabbit aorta than the known selective B1 BK receptor antagonist, desArg9-[Leu8]BK (IC50 1.1 X 10(-7) M). DesArg9-D-Arg[Hyp3,Thi5,D-TiC7,OiC8]BK is the desArg10) derivative of Hoe140, a new, potent, stable, selective and long-acting B2 BK receptor antagonist. In B2 organ preparation it was three orders of magnitude less potent than Hoe140. Since it is potent and stable it could contribute to the investigation of B1 BK receptor function.
引用
收藏
页码:217 / 218
页数:2
相关论文
共 7 条
[1]   BRADYKININ RECEPTOR ANTAGONISTS [J].
BURCH, RM ;
FARMER, SG ;
STERANKA, LR .
MEDICINAL RESEARCH REVIEWS, 1990, 10 (02) :237-269
[2]  
HOCK FJ, 1991, BRIT J PHARMACOL, V102, P769, DOI 10.1111/j.1476-5381.1991.tb12248.x
[3]   PHARMACOLOGY OF KININS - THEIR RELEVANCE TO TISSUE-INJURY AND INFLAMMATION [J].
MARCEAU, F ;
LUSSIER, A ;
REGOLI, D ;
GIROUD, JP .
GENERAL PHARMACOLOGY, 1983, 14 (02) :209-229
[4]   RECEPTORS FOR BRADYKININ IN RABBIT AORTAE [J].
REGOLI, D ;
BARABE, J ;
PARK, WK .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1977, 55 (04) :855-867
[5]  
REGOLI D, 1980, PHARMACOL REV, V32, P1
[6]  
TAYLOR JE, 1989, DRUG DEVELOP RES, V61, P1
[7]   HOE-140 A NEW POTENT AND LONG-ACTING BRADYKININ-ANTAGONIST - INVIVO STUDIES [J].
WIRTH, K ;
HOCK, FJ ;
ALBUS, U ;
LINZ, W ;
ALPERMANN, HG ;
ANAGNOSTOPOULOS, H ;
HENKE, S ;
BREIPOHL, G ;
KONIG, W ;
KNOLLE, J ;
SCHOLKENS, BA .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 102 (03) :774-777